Merus Announces Second Quarter 2016 Financial Results and Reviews Recent Clinical Progress and Corporate Developments

Go back to Merus Announces Second Quarter 2016 Financial Results and Reviews Recent Clinical Progress and Corporate Developments
(NASDAQ: MRUS) Delayed: 90.00 --0 (-0%)
Previous Close $90.00    52 Week High $19.63 
Open $90.00    52 Week Low $7.26 
Day High $90.00    P/E N/A 
Day Low $90.00    EPS $0.00 
Volume 720,454